With more than 120 years devoted to anti-infectives, Xellia Pharmaceuticals develops and manufactures fermentation-based non-beta-lactam medicines, supplying APIs and finished dosage forms for severe infections. Based in Copenhagen with manufacturing in Europe and Asia, it is one of the last Western producers of several essential anti-infective APIs and supplies more than 500 pharmaceutical companies across 80 countries. Its defining focus is continuity: keeping complex, critical medicines available through long-term manufacturing expertise and investment.
Par HealthPar Health makes essential medicines, including active pharmaceutical ingredients, generic drugs and sterile injectables, through a global manufacturing network. Formed from the merger of Mallinckrodt and Endo, the company carries more than 160 years of pharmaceutical experience, including a St. Louis API site with roots reaching back over 160 years. With 10 manufacturing facilities, two R&D centers and products reaching more than 70 countries, Par Health combines that long industrial history with a broad modern supply network.HOBART, NY
SERB PharmaceuticalsSERB Pharmaceuticals develops, manufactures, and supplies specialist medicines for rare diseases and medical emergencies, with a particular strength in antidotes and other critical-care treatments. Beginning in the 1950s as Société d’Études et de Recherches Biologiques, the company now supplies more than 70 medicines through direct operations and distribution partners in over 100 countries. Its fully integrated platform includes a commercial-scale polyclonal antibody manufacturing capability and four manufacturing facilities across three continents.325412CONSHOHOCKEN, PA
ActylisWith more than 75 years in the trade, Actylis sources and manufactures critical ingredients and raw materials for pharmaceutical, biopharmaceutical, nutrition and specialty-chemical makers. Its global network combines in-house production with tailored sourcing, process development and supply-chain support, including a 30,000-square-foot cGMP API facility in Eugene and Water for Injection capabilities in Montreal. Actylis operates ISO 9001:2015-certified facilities and supports customers from early development through commercial-scale production.GRAND ISLAND, NY
MedichemFounded in 1972, Barcelona-based Medichem develops and manufactures pharmaceutical active ingredients and finished drug products as a vertically integrated CDMO. Its distinctive specialty is chlorhexidine: Medichem has made chlorhexidine salts since 1985 and identifies itself as the only manufacturer and supplier of chlorhexidine in Europe. With more than 450 employees, facilities in Spain and Malta, and B Corp status, the company serves customers in over 60 countries.NEW YORK, NY